
|Articles|April 24, 2006
Accredo wins Flolan agreement
Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
2
A1c Monitoring Could Be Delayed Up to 2 Years for Patients With Type 2 Diabetes
3
Why It’s Crucial to Address Insulin Resistance During Pregnancy
4
Wicked Good Cardiometabolic Chat: SGLT2is Offer Cardiorenal Benefits Beyond Diabetes
5




















































































































































